Changeflow GovPing Courts & Legal VA Cooperative Studies Program Importer Control...
Routine Notice Added Final

VA Cooperative Studies Program Importer Controlled Substances

Favicon for www.federalregister.gov FR: Drug Enforcement Administration
Published
Detected
Email

Summary

The DEA published notice that VA Cooperative Studies Program applied on April 9, 2026, to be registered as an importer of controlled substances for research purposes. The application covers Marihuana Extract (Drug Code 7350) and Tetrahydrocannabinols (Drug Code 7370), Schedule I controlled substances, which the company plans to import as finished dosage unit products for clinical trial studies only. The DEA is accepting electronic comments and written hearing requests on the application through May 21, 2026.

“The company plans to import finished dosage unit products containing the above listed controlled substances for research and clinical trial studies only.”

Published by Justice Department on federalregister.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The DEA published a notice of application from VA Cooperative Studies Program to be registered as an importer of two Schedule I controlled substances: Marihuana Extract (7350) and Tetrahydrocannabinols (7370). The company seeks authorization to import finished dosage unit products containing these substances exclusively for research and clinical trial studies. No other activities are authorized under this registration.

Affected parties include registered bulk manufacturers and applicants who may submit comments or objections to the proposed registration on or before May 21, 2026. Written requests for hearings must be sent to designated DEA addresses in Springfield, Virginia. The registration, if approved, would only authorize import for research purposes consistent with 21 U.S.C. 952(a)(2); commercial sale of FDA-approved or non-approved finished dosage forms remains outside the scope of this authorization.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Notice

Importer of Controlled Substances Application: VA Cooperative Studies Program

A Notice by the Drug Enforcement Administration on 04/21/2026

  • This document has a comment period that ends in 30 days.
    (05/21/2026) View Comment Instructions

  • PDF

  • Document Details

  • Document Dates

- Table of Contents

  • Public Comments
  • Regulations.gov Data

- Sharing

  • Print
  • Other Formats
  • Public Inspection Published Document: 2026-07697 (91 FR 21314) Document Headings ###### Department of Justice
Drug Enforcement Administration
  1. [Docket No. DEA-1705]

AGENCY:

Drug Enforcement Administration, Justice.

ACTION:

Notice of application.

SUMMARY:

VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 21, 2026. Such persons may also file a written request for a hearing on the application on or before May 21, 2026.

ADDRESSES:

The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.34(a), this is notice that on April 9, 2026, VA Cooperative Studies Program, 2401 Centre Avenue Southeast, Albuquerque, New Mexico 87106, applied to be registered as an importer of the following basic class(es) of controlled substance(s):

| Controlled substance | Drug
code | Schedule |
| --- | --- | --- |
| Marihuana Extract | 7350 | I |
| Tetrahydrocannabinols | 7370 | I |
The company plans to import finished dosage unit products containing the above listed controlled substances for research and clinical trial studies only. No other activities for these drug codes are authorized for this registration.

Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.

Thomas Prevoznik,

Deputy Assistant Administrator.

[FR Doc. 2026-07697 Filed 4-20-26; 8:45 am]

BILLING CODE P

Published Document: 2026-07697 (91 FR 21314)

CFR references

21 CFR 1301.34(a)

Citations

21 CFR 1301.34(a) authority for application notice requirement
21 U.S.C. 952(a)(2) limits authorized import activity to research consistent with statute

Get daily alerts for FR: Drug Enforcement Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Justice Department.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Justice Department
Published
April 21st, 2026
Comment period closes
May 21st, 2026 (30 days)
Compliance deadline
May 21st, 2026 (30 days)
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
91 FR 21314 / Docket No. DEA-1705
Docket
Docket No. DEA-1705

Who this affects

Applies to
Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Controlled substances import Clinical trial supplies Research registration
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Healthcare Research & Development

Get alerts for this source

We'll email you when FR: Drug Enforcement Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!